tm logo
alyftrek
FORMALIZED

on 20 Nov 2024

Last Applicant/ Owned by

Vertex Pharmaceuticals Incorporated

50 Northern AvenueBoston MA 02210

US

Serial Number

2363638 filed on 15th Oct 2024

alyftrek

Vienna Information


24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 6

Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Trademark usage description

pharmaceutical preparations for the treatment of cystic fibrosis.

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis.


Classification kind code

12

Mark Details


Serial Number

2363638

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 21st Nov 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 20th Nov 2024
Created
Submitted for opposition 31
on 20th Nov 2024
Formalized
Submitted for opposition 30
on 15th Oct 2024
Filed
Submitted for opposition 228
on 15th Oct 2024
International Registration